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Abstract
High blood concentrations of n-6 fatty acids (FAs) relative to n-3 FAs may lead to a ‘‘physiological switch’’ towards
permanent low-grade inflammation, potentially influencing the onset of cardiovascular and inflammatory diseases, as well
as cancer. To explore the potential effects of FA ratios prior to disease onset, we measured blood gene expression profiles
and plasma FA ratios (linoleic acid/alpha-linolenic acid, LA/ALA; arachidonic acid/eicosapentaenoic acid, AA/EPA; and total
n-6/n-3) in a cross-section of middle-aged Norwegian women (n = 227). After arranging samples from the highest values to
the lowest for all three FA ratios (LA/ALA, AA/EPA and total n-6/n-3), the highest and lowest deciles of samples were
compared. Differences in gene expression profiles were assessed by single-gene and pathway-level analyses. The LA/ALA
ratio had the largest impact on gene expression profiles, with 135 differentially expressed genes, followed by the total n-6/
n-3 ratio (125 genes) and the AA/EPA ratio (72 genes). All FA ratios were associated with genes related to immune
processes, with a tendency for increased pro-inflammatory signaling in the highest FA ratio deciles. Lipid metabolism
related to peroxisome proliferator-activated receptor c (PPARc) signaling was modified, with possible implications for foam
cell formation and development of cardiovascular diseases. We identified higher expression levels of several autophagy
marker genes, mainly in the lowest LA/ALA decile. This finding may point to the regulation of autophagy as a novel aspect
of FA biology which warrants further study. Lastly, all FA ratios were associated with gene sets that included targets of
specific microRNAs, and gene sets containing common promoter motifs that did not match any known transcription factors.
We conclude that plasma FA ratios are associated with differences in blood gene expression profiles in this free-living
population, and that affected genes and pathways may influence the onset and progression of disease.
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Introduction
The type and amount of fatty acids (FAs) in a person’s diet
determine the relative amounts of FAs in the tissues of the body,
and may influence the pathogenesis of cardiovascular and
inflammatory diseases, as well as cancer [1–3]. A multitude of
mechanisms have been shown to influence disease pathogenesis,
including lipid metabolism and inflammation. To study the
complex molecular mechanisms involved in the association
between nutritional factors and multifactorial diseases, high-
throughput technologies like transcriptomics are increasingly
being used.
The importance of dietary fat is mirrored in the complexity of
FA metabolism. After ingestion, or following lipolysis in adipose
tissue, FAs enter the blood stream either esterified in lipoproteins
or non-esterified bound to albumin. FAs are transported into cells
throughout the body, where they may be degraded by (per-)
oxidation, stored as triglycerides, or incorporated into the
phospholipids of cellular membranes. Membrane phospholipids
can be modified into lipid mediators such as inositol triphosphate
(IP3), and FAs residing in the cellular membranes can be mobilized
through the action of phospholipases and undergo modifications to
yield a variety of immunoactive eicosanoids. Furthermore, FAs are
potent regulators of gene expression via receptors like the
peroxisome proliferator-activated receptors (PPARs) [4,5]. Collec-
tively, PPARs and their binding partners, retinoid X receptors
(RXR), regulate cellular and physiological processes including FA
metabolism, cellular stress, and inflammation.
A key aspect of FA biology is the specificity inferred by the FA
structure, as well as the fact that dietary sources differ in the FAs
they contain. Two long-chain polyunsaturated FAs (PUFAs) are
essential to humans and must be obtained from the diet: linoleic
acid (LA, 18:2 n-6) and alpha-linolenic acid (ALA, 18:3 n-3), both
of which are derived mainly from plant oils. LA is metabolized to
arachidonic acid (AA, 20:4 n-6), whereas ALA is converted to
eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid
(DHA, 22:6 n-3). This metabolism of PUFAs is extremely limited
in humans [6]. In addition, mammals cannot convert n-6 FAs to n-
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3 FAs [7], making the two classes metabolically distinct. n-6 and n-
3 PUFAs compete for the same enzyme systems, so that the
conversion of ALA to EPA and DHA is further reduced in
individuals who adhere to a Western diet, due to the high intake of
LA. Hence, EPA and DHA are mainly provided from dietary
marine sources.
It has been suggested that n-6 FAs are pro-inflammatory,
whereas n-3 FAs are much less so, and sometimes even anti-
inflammatory. The ratio of n-6/n-3 FAs has been implicated in the
pathogenesis of conditions like inflammatory and cardiovascular
diseases, as well as cancers of the breast, prostate and colon
[1,8,9]. A dietary n-6/n-3 ratio of 1 may be considered healthy,
corresponding to a 50% n-3 FA content in tissues, but the typical
Western diet provides a considerably higher n-6/n-3 ratio [10].
However, a relatively high n-3 intake and low n-6/n-3 ratio is
observed in Norwegians, who consume high amounts of fish, fish
products and fish oil supplements compared to other Western
populations [11,12]. Effects of dietary intervention studies to
reduce the n-6/n-3 ratio in healthy subjects include a reduced
number of platelets and leukocytes [13], and beneficial modulation
of metabolic and inflammatory markers [14,15]. The involvement
of inflammatory mechanisms in the association between n-6/n-3
ratio and disease has led to the hypothesis that a high n-6/n-3 ratio
may cause a ‘‘physiological switch’’ towards a permanent state of
low-grade inflammation, which may be detrimental to several
aspects of human health [1,16].
Despite the overarching hypothesis of a ‘‘physiological inflam-
matory switch’’, genome-wide transcriptomics studies exploring
the potential effects of the n-6/n-3 ratio in the general population
are scarce. However, some intervention studies have used FA
supplementation to investigate the effects on gene expression
levels. One targeted study of healthy adults showed reduced
expression of selected signal transduction genes and pro-inflam-
matory cytokines after a 40% reduction of the n-6/n-3 ratio [17].
In addition, short and long-term effects of FA supplementation on
genome-wide transcription in blood cells has been investigated
[18]. Postprandial gene expression changes were found in
peripheral blood mononuclear cells (PBMCs) after a DHA-rich
meal, including up-regulation of stress genes and down-regulation
of lipid metabolism [19]. After long-term supplementation (26
weeks) with EPA/DHA in an elderly population, PBMC gene
expression levels related to inflammatory and atherogenic
pathways were decreased [5].
Taken together, molecular and epidemiological studies indicate
the importance of the n-6/n-3 ratio in relation to the prevention of
inflammatory and cardiovascular diseases, as well as cancer.
However, the use of the n-6/n-3 ratio to monitor and modify risk
factors related to human disease is not without controversy [20].
One important objection stems from the fact that the total n-6/n-3
ratio, which is often used in epidemiological studies, does not
distinguish between different types of PUFAs, e.g. LA/ALA or
AA/EPA ratios. Furthermore, the extrapolation of the positive
effects of FA ratios on disease, to their potential effects during
disease onset, has not been extensively evaluated. With the aim of
exploring the potential mechanisms of FA ratios in disease
prevention, we used data from the Norwegian Women and
Cancer (NOWAC) Post-genome Cohort [21] to perform a cross-
sectional analysis of middle-aged Norwegian women. We grouped
the study population according to three plasma FA ratios (LA/
ALA, AA/EPA and total n-6/n-3), and identified differences in
blood gene expression profiles by comparing the highest versus the
lowest FA ratio deciles. To our knowledge, the present study is the
first to explore the genome-wide transcriptomic effects of FA ratios
in a representative cohort.
Materials and Methods
Study Population and Materials
The NOWAC Study [22] and the NOWAC Post-genome
Cohort [21] have been described in detail elsewhere. Briefly, the
Post-genome Cohort consists of 50 000 women born between
1943 and 1957. Invited women were asked to visit their general
physician to have blood collected using a kit which they
received by mail, and to answer a two-page questionnaire on
anthropometric and lifestyle parameters (including use of dietary
supplements, medication, and menstrual status). Blood samples
and questionnaires were returned by mail to the NOWAC study
center. A total of 500 women were randomly selected for the
present study, 444 of whom returned blood samples and
questionnaires during 2005 (response rate 89%). All women
included in our study population successfully returned a citrate-
buffered blood sample, and a PAXgene blood RNA collection
tube, which conserves the RNA profile of all circulating cells
(Preanalytix, Qiagen, Hilden, Germany). Blood samples were
required to reach the study center and be frozen no more than
3 days after blood collection. Furthermore, all included women
were required to be postmenopausal according to self-report
and plasma hormone levels (99 excluded) [23]. Medication was
classified into the following categories: diabetes, non-steroidal
anti-inflammatory drugs (NSAIDs), statins, cardiovascular med-
ication (diuretics, adrenergic beta antagonists, calcium channel
blockers, renin-angiotensin system inhibitors (including combi-
nations with diuretics) and other anti-hypertensives), and
immune system-related medication. Based on this classification,
30 women taking diabetes medication, statins, and immune
system-related medication were excluded. In addition, two
women using anti-thrombotics, and one using hydroxychloro-
quine were excluded from the study. Women were not required
to fast before blood collection, but those who had not eaten for
12 h or more were defined as fasting. Women who had smoked
during the week before blood collection were defined as
smokers, and those who had taken n-3 capsules/oils and/or
cod liver oil the week before blood collection were defined as
users of n-3 supplements.
Ethics Statement
The NOWAC Post-genome Cohort study was approved by the
Regional Committee for Medical Research Ethics and the
Norwegian Data Inspectorate. All participants gave written
informed consent.
RNA Extraction and Gene Expression Profiling
Details of experimental procedures have been described
elsewhere [24]. Total RNA was isolated using the PAXgene
Blood RNA Isolation Kit (Preanalytix, Qiagen, Hilden, Germany),
according to the manufacturer’s protocol. RNA quantity, quality
and integrity were assessed using the NanoDrop ND1000
spectrophotometer (Thermo Scientific, Wilmington, Delaware,
USA) and the Experion automated electrophoresis system (BioRad
Laboratories, Hemel Hempstead, UK); 39 samples were excluded
due to low RNA quality or quantity. No globin reduction method
was used, in line with our previous finding that showed no major
benefit from reduction of globin RNA for the microarray platform
employed in the present study [25]. Gene expression levels were
measured using the Human Genome Survey Microarray V2.0
(Applied Biosystems, ABI, Life Technologies, Carlsbad, California,
USA). The microarray contains 32 878 probes for the interroga-
tion of 29 098 transcripts. ABI Expression System software was
used to extract signal intensities and signal/noise ratios, and for
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flagging of spots. Experimental details and required data files were
submitted to Gene Expression Omnibus (ww.ncbi.nlm.nih.gov/
geo), under accession number GSE15289.
Microarray Data Preprocessing and Normalization
The Bioconductor/R statistical package was used for micro-
array data preprocessing (script available upon request). Standard
ABI exclusion criteria were applied, removing probes with a
signal/noise ratio of less than 3, or those that were flagged as
irregular by the scanner. There were 10 784 probes that met the
selection criteria, and these were included in the gene expression
matrix. Missing values were imputed using the k-nearest neighbor
method [26]. Arrays that displayed an irregular intensity pattern in
the built-in controls were removed (n = 3). The gene expression
data set was normalized using a quantile and control-based
normalization approach [27] (script available upon request).
Probes with very low variability (,0.1), or very low average log2
signal (,9.5), were removed.
FA Measurements
The National Institute of Nutrition and Seafood Research
analyzed 34 unique FAs in citrate-buffered plasma samples, using
rapid gas chromatography [28]. Failed measurements caused eight
samples to be excluded. FA ratios were calculated from the mass of
each FA.
Statistical Analysis
The final number of included women was 227. For this
explorative analysis, gene expression matrices were generated by
arranging samples (columns) from highest to lowest values for the
three FA ratios considered (LA/ALA, AA/EPA and total n-6/n-
3). Within each matrix only the highest and lowest decile of
samples were compared (decile n = 23). Potential confounders
were evaluated by comparing the highest and lowest deciles using
independent sample t-tests with two-tailed p-values, Mann-
Whitney U tests, and Chi square tests (SPSS Statistics 19, IBM,
Armonk, New York), with p,0.01 as the significance threshold.
There was a small, but statistically significant age difference
among women in the highest versus the lowest AA/EPA and total
n-6/n-3 deciles. Changes in lipid metabolism during menopausal
transition have been well characterized, but as of yet, time since
menopause has not been reported to influence lipid profiles [29].
Because all of our study women were postmenopausal, we chose
not to adjust for age in the analyses of gene expression profiles. T-
tests in R, and Benjamini-Hochberg corrected p-values were used
to evaluate differential gene expression between the highest and
the lowest LA/ALA, AA/EPA and total n-6/n-3 deciles.
Functional annotations of single genes were explored using
www.genecards.org and The Database for Annotation, Visualiza-
tion and Integrated Discovery v. 6.7 [30]. Lists of differentially
expressed genes were evaluated for potential overlap with
previously reported gene sets using the Molecular Signatures
Database (MSigDB) v. 3.0 (www.broadinstitute.org/gsea/msigdb)
[31], limited to collections C2 CP (Kyoto Encyclopedia of Genes
and Genomes Pathway Database, KEGG, Biocarta, Reactome),
C3 (microRNA, miRNA, targets, transcription factor targets), and
C5 (Gene Ontology, GO). Gene Set Enrichment Analysis (GSEA)
[31] in R was used for functional interpretation based on gene sets
from KEGG, GO and Panther. False discovery rate (FDR) ,25%
and nominal p,0.05 were used as significance thresholds in
GSEA.
Results
Our study population (n = 227) was slightly overweight, and
one-quarter of them were smokers (Table 1). A majority of the
study women had taken n-3 supplements, in concordance with
previous findings in the Norwegian population [12]. Neverthe-
less, the population mean of all FA ratios was dominated by n-6
FAs. The mean LA/ALA ratio was approximately 50, mean
AA/EPA ratio was approximately 4, and mean total n-6/n-3
ratio was approximately 6. The highest and lowest FA ratio
deciles included 23 women each, and their characteristics are
presented in Table 2 and Supplementary Table S1. There were
no significant differences in body mass index, smoking, fasting
and medication use between comparison groups (p,0.01).
There were no significant differences in main characteristics
between the highest and lowest LA/ALA deciles. When
comparing the highest versus the lowest AA/EPA deciles, the
lowest decile was slightly older and had a higher frequency of
n-3 supplement use. The same pattern of age and supplement
use was present in the comparison of the highest versus the
lowest total n-6/n-3 deciles. In the study population as a whole,
users of n-3 supplements were slightly older than non-users (2
years older, p,0.01, data not shown), but the age difference
was statistically significant. The frequent use of supplements
may be related to the AA/EPA ratio of the lowest AA/EPA
decile and the lowest total n-6/n-3 decile (AA/EPA ratio 1.3
and 1.5, respectively), which may be regarded as balanced
(Table 2). There were no significant differences between any of
the FA ratio deciles regarding technical variables (time elapsed
between blood collection and freezing of the blood sample, date
of RNA extraction, or microarray lot numbers, data not shown).
The LA/ALA ratio was associated with the highest number of
differentially expressed genes (Table 3, t-tests, adjusted p#0.01, 315
genes), followed by the total n-6/n-3 ratio (125 genes), and the AA/
EPA ratio (72 genes). We present the top 10 up- and down-regulated
genes (Table 4–6), and complete gene lists are available (Supple-
Table 1. Characteristics of the 227 women in the study
populationa.





Time since meal (h) 2.763.7
n-3 supplements 130 (59%)
NSAIDs 20 (9%)





aFormat for age, BMI, time since meal, and FA ratios: mean (standard deviation).
Format for smoking, fasting, supplements and medication: frequency (percent).
Missing: BMI: 3, smoking: 1, fasting: 27, n-3 supplements: 5.
Abbreviations: AA: arachidonic acid, ALA: alpha-linolenic acid, BMI: body
mass index, EPA: eicosapentaenoic acid, h: hours, HRT: hormone replacement
therapy, LA: linoleic acid, n-3 supplements: any combination of n-3 capsules/
oils, cod liver oil or both, NSAIDs: non-steroidal anti-inflammatory drugs.
doi:10.1371/journal.pone.0067270.t001
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mental Tables S2–S4). All tables contain gene symbols and
corresponding gene names. Gene expression profiles according to
AA/EPA and total n-6/n-3 ratios overlapped slightly more than the
gene expression profile according to LA/ALA ratio, and no genes
were shared across all three ratios (Supplemental Figure S1). As
often seen when studying human complex tissues in a non-
experimental setting, the biological variation between individuals
was large and the magnitude of detectable gene expression changes
was small: no transcripts changed more than approximately 1.4-fold
between groups. Differentially expressed genes resulting from the
comparison of the highest versus the lowest LA/ALA deciles
included inflammatory markers like receptor subunits for IL1 and
IL10 (IL1R2, IL10RB), chemokines (CCL7, CCL24), and TLR8
(Table 4 and Supplemental Table S2). Key FA metabolism
regulators were differentially expressed, including PPARc binding
partners. Interestingly, genes related to autophagy were more highly
expressed in the lowest LA/ALA decile, including KIAA0831 and
OPTN. The list of differentially expressed genes overlapped with 50
gene sets in MSigDB belonging to two major categories (Table 7
and Supplemental Table S5): one category involving immune
processes, with up to 20% overlap (e.g. the IL10 pathway, NO2-
dependent IL12 pathway, and Systemic Lupus Erythematosus
pathway), and one related to function, packaging, maintenance and
repair of DNA and RNA (e.g. Reactome unwinding of DNA, 18%
overlap). A significant overlap with gene sets corresponding to
targets of two miRNAs was identified, as well as with three gene sets
with common promoter motifs. However, neither motif matched
any known transcription factors. According to GSEA (Table 8), the
Jak/STAT pathway was positively enriched in the highest LA/ALA
decile.
When comparing the highest versus the lowest AA/EPA deciles,
differentially expressed genes included the PPARc target ABCG1
(Table 5 and Supplemental Table S3). Very few inflammatory
genes were associated with the AA/EPA ratio. The list of
differentially expressed genes overlapped with 24 gene sets mainly
related to catabolic processes and fat metabolism, including
phospholipid transport (17% overlap), and targets of transcription
factors like LXRA/NR1H3 and RXRB (Table 7 and Supple-
mental Table S6). Seven gene sets that included targets of specific
miRNAs were significant, including MIR-103/107 and MIR-7.
GSEA revealed significant negative enrichment for sulfur metab-
olism in the highest AA/EPA decile (Table 8).
Differentially expressed genes resulting from the comparison of
the highest versus the lowest total n-6/n-3 deciles included
ABCG1, OSBP2 and PLA2, all involved in FA and lipid
metabolism (Table 6 and Supplemental Table S4). The list of
differentially expressed genes overlapped up to 14% with gene sets
related to endoplasmic reticulum and Golgi function, vesicle
transport and protein folding (Table 7 and Supplemental Table
S7). Apoptotic gene sets were identified, as well as two miRNA
target sets: MIR-326 and MIR-296. In addition, differentially
expressed genes overlapped with two gene sets sharing promoter
motifs that did not match any known transcription factors.
According to GSEA, no pathways were significantly enriched
according to total n-6/n-3 ratio.
Discussion
In this explorative analysis, we investigated LA/ALA, AA/EPA
and total n-6/n-3 ratios measured in plasma, and their potential
Table 2. Characteristics of the highest and lowest fatty acid ratio decilesa.
LA/ALA ratio AA/EPA ratio n6/n3 ratio
Highest decile
Lowest
decile p Highest decile Lowest decile p Highest decile Lowest decile p
Age 5563.7 5563.3 0.97 5463.5 5763.0 ,0.01 5363.3 5763.2 ,0.01
BMI 2462.8 2663.6 0.17 2464.0 2362.5 0.4 2363.8 2464.0 0.47
Smoking 8 (35%) 5 (22%) 0.51 8 (36%) 2 (9%) 0.04 8 (36%) 3 (13%) 0.14
Fasting 3 (16%) 1 (5%) 0.33 2 (10%) 0 0.23 0 0 NA
Time since meal (h) 3.765.1 1.962.6 0.24 3.264.1 1.961.7 0.18 1.761.2 2.262.4 0.72
n-3 suppl. 12 (52%) 14 (61%) 0.77 3 (14%) 21 (91%) ,0.01 4 (18%) 22 (96%) ,0.01
NSAIDs 2 (9%) 0 0.49 4 (17%) 1 (4%) 0.35 5 (22%) 3 (13%) 0.70
Cardiovascular
medication
3 (13%) 5 (22%) 0.70 4 (17%) 0 0.11 2 (9%) 1 (4%) 1.00
HRT 5 (22%) 2 (9%) 0.41 9 (17%) 3 (13%) 0.09 8 (35%) 3 (13%) 0.07
LA/ALA 86.8614.2 2665.0 ,0.01 61.0623.9 46.4616.4 0.02 62.1623.9 45.5615.0 0.01
AA/EPA 4.963.1 3.261.9 0.02 10.462.8 1.360.2 ,0.01 9.262.8 1.560.5 ,0.01
n-6/n-3 6.962.3 5.061.6 ,0.01 9.561.8 3.460.8 ,0.01 10.061.4 3.160.5 ,0.01
aDecile n = 23. Subgroups may not total 227 due to missing values.
Abbreviations: AA: arachidonic acid, ALA: alpha-linolenic acid, BMI: body mass index, EPA: eicosapentaenoic acid, h: hours, HRT: hormone replacement therapy, LA:
linoleic acid, n-3 suppl.: any combination of n-3 capsules/oils, cod liver oil or both, NSAIDs: non-steroidal anti-inflammatory drugs.
doi:10.1371/journal.pone.0067270.t002





LA/ALA 315 168 147
AA/EPA 72 35 37
n-6/n-3 125 46 79
Abbreviations: AA: arachidonic acid, ALA: alpha-linolenic acid, EPA:
eicosapentaenoic acid, FA: fatty acid, LA: linoleic acid.
doi:10.1371/journal.pone.0067270.t003
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Table 4. Top 10 up- and down-regulated genes associated with LA/ALA ratio (p#0.01)a.
Gene symbol Gene name ABI probe ID Entrez gene ID Mean difference
HDC Histidine decarboxylase 194873 3067 1.41
CPA3 Carboxypeptidase A3 (mast cell) 100989 1359 1.36
TCHHL1 Trichohyalin-like 1 (basalin, S100 calcium-binding protein A17) 132590 126637 1.20
MYBPHL Myosin binding protein H-like 201601 343263 1.18
FcER1B FC epsilon receptor I beta-chain (MS4A2) 182643 2206 1.00
ANPEP Alanyl (membrane) aminopeptidase (CD13) 102558 290 0.64
GLT1D1 Glycosyltransferase 1 domain-containing protein 1 185381 144423 0.63
ZNF558 Zinc finger protein 558 124882 148156 0.63
SLC22A9 Solute carrier family 22 (organic anion/cation transporter) 9 206544 114571 0.62
FABP4 Fatty acid binding protein 4, adipocyte 150137 2167 0.61
IFIT1L Interferon-induced protein with tetratricopeptide repeats 1B 112888 439996 20.75
MINPP1 Multiple inositol polyphosphate phosphatase 1 188640 9562 20.70
OR2W3 Olfactory receptor 2W3 702434 343171 20.70
FAM63B Family with sequence similarity 63, member B 161432 54629 20.69
GFI1 Growth factor independent 1 transcription repressor (ZNF163) 121984 2672 20.69
MATR3 Matrin 3 229698 9782 20.66
SNCA Synuclein, alpha (non A4 comp. of amyloid precursor) 170285 6622 20.63
MYBL1 V-myb myeloblastosis viral oncogene homolog (avian)-like 1 207803 4603 20.63
NR2C2AP Nuclear receptor 2C2-associated protein 211955 126382 20.59
KLRG1 Killer cell lectin-like receptor subfamily G, member 1 188801 10219 20.58
aComplete lists of differentially expressed genes (p#0.01) are given in Supplemental Table S2.
Abbreviations: ABI: Applied Biosystems, ALA: alpha-linolenic acid, LA: linoleic acid.
doi:10.1371/journal.pone.0067270.t004
Table 5. Top 10 up- and down-regulated genes associated with AA/EPA ratio (p#0.01)a.
Gene symbol Gene name ABI probe ID Entrez gene ID Mean difference
ABCB9 ATP-binding cassette, sub-family B (MDR/TAP), member 9 155893 23457 0.68
ZNF354A Zinc finger protein eZNF (transcription factor 17) 214609 6940 0.64
ENTPD4 Ectonucleoside triphosphate diphosphohydrolase 4 (LYSAL1) 226738 9583 0.56
ZCCHC2 Zinc finger, CCHC domain-containing protein 2 154456 54877 0.51
RNMTL1 RNA methyltransferase-like protein 1 135382 55178 0.51
GRIN2C Glutamate receptor, ionotropic, N-methyl D-aspartate 2C 194729 2905 0.47
PODNL1 Podocan-like 1 146598 79883 0.47
CCL24 Chemokine (C-C motif) ligand 24 128049 6369 0.44
RNF157 Ring finger protein 157 212544 114804 0.40
C20orf26 Chromosome 20 open reading frame 26 150962 26074 0.35
HLA-DQA1 Major histocompatibility complex, class II, DQ alpha 1 170258 3117 21.04
LMOD2 Leiomodin 2 (cardiac) 187222 442721 20.80
APLP2 Amyloid beta (A4) precursor-like protein 2 223157 334 20.74
GPR97 G protein-coupled receptor 97 112591 222487 20.61
FBXO17 F-box protein 17 163400 115290 20.46
TMEM132B Transmembrane protein 132B 167812 114795 20.44
PTK2 Protein-tyrosine kinase 2 (FAK) 128624 5747 20.44
OSBP2 Oxysterol-binding protein 2 148957 23762 20.43
C4orf22 Chromosome 4 open reading frame 22 164838 255119 20.39
ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1 210662 9619 20.39
aComplete lists of differentially expressed genes (p#0.01) are given in Supplemental Table S3.
Abbreviations: AA: arachidonic acid, ABI: Applied Biosystems, EPA: eicosapentaenoic acid.
doi:10.1371/journal.pone.0067270.t005
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effect on blood gene expression in a cross-section of middle-aged
Norwegian women. Despite the high consumption of fish and n-3-
rich fish oil supplements among Norwegians [11,12], the
population mean of all FA ratios was dominated by n-6 PUFAs.
However, the AA/EPA ratio in the lowest AA/EPA and total n-6/
n-3 deciles may be regarded as ‘‘balanced’’, and reflects the
frequent use of EPA-rich n-3 supplements in these groups.
When comparing the highest versus the lowest FA ratio deciles,
genes and pathways related to inflammation were differentially
expressed in all three considered FA ratios. In addition, the
identification of genes related to lipid metabolism and autophagy
may point to the importance of these processes in elucidating the
molecular mechanism related to the differing health effects of n-6
versus n-3 FAs. In general, FAs may influence gene expression
profiles via several routes. These include direct mechanisms, such
as binding to nuclear transcription factors, but also indirect
mechanisms such as production of IP3 and DAG. These second
messengers lead to modulation of cellular functions and secretion
of signaling molecules including eicosanoids. Eicosanoids and
related compounds act in a paracrine manner, and may influence
the expression profiles of adjacent cells. The gene expression
profiles presented here must be viewed as a combined read-out of
these mechanisms in blood cells.
FA Ratios and Inflammatory Signaling
Molecular and epidemiological studies have demonstrated the
immunoregulatory effects of dietary FAs. In the present study, the
LA/ALA ratio was associated with the largest number of
differentially expressed genes compared to the other ratios, both
for all genes combined, and regarding genes involved in
inflammatory processes. At the pathway level, GSEA revealed
that the pleiotropic Jak/STAT pathway was enriched in the
highest LA/ALA decile. This pathway is regarded as a principal
signaling cascade for numerous cytokines, and its enrichment in
the highest LA/ALA decile may be related to the higher level of
expression of several cytokines, chemokines, and corresponding
receptors and activators in the same group (including IL1R2,
IL10RB, CCL7, TLR8). Also, several pathways related to
cytokines were among the overlapping gene sets reported in
MSigDB. In line with the present findings in a free-living
population that consumes high amounts of fish and n-3
supplements, several studies have reported that long-term fish oil
supplementation may reduce cytokine production [18], with a
potential benefit for inflammatory disease pathogenesis.
A key pro-inflammatory component of innate and adaptive
immunity, TLR8, was up-regulated in the highest LA/ALA decile.
Studies have shown that dietary n-3 FAs inhibit TLRs, with
positive consequences for inflammatory and immune responses
[32,33]. Furthermore, the expression level of TLR8 correlated
with poor outcome and increased inflammation in ischemic stroke
[34]. TLR8 is highly expressed in peripheral blood leukocytes, and
upon activation leads to NF-kB activation and secretion of
cytokines. In conjunction with the higher expression levels of
cytokines and related factors in the highest LA/ALA decile, TLR8
expression level may be indicative of higher inflammatory status in
this group. In support of this hypothesis, the receptor for the pro-
inflammatory platelet activating factor, PTAFR, was up-regulated
in the highest LA/ALA decile. PTAFR is known to trigger
inflammatory and thrombotic cascades, and is important for
development of cardiovascular disease. In a dietary intervention
study, Ambring et al. [13] found reduced numbers of platelets after
reducing the n-6/n-3 ratio, which may be mirrored in our data as
Table 6. Top 10 up- and down-regulated genes associated with total n-6/n-3 ratio (p#0.01)a.
Gene symbol Gene name ABI probe ID Entrez gene ID Mean difference
SERPINB9 Serpin peptidase inhibitor, clade B (ovalbumin), member 9 (PI9) 113696 5272 0.57
MSMO1 Methylsterol monooxygenase 1 (SC4MOL) 157577 6307 0.56
SNAP23 Synaptosomal-associated protein, 23 kD 188605 8773 0.55
CACNB1 Calcium channel, voltage-dependent, beta 1 subunit 206077 782 0.51
SLC30A5 Solute carrier family 30 (zinc transporter), member 5 209725 64924 0.51
ISLR Immunoglobulin superfamily containing leucine-rich repeat 103786 3671 0.48
CCDC78 Coiled-coil domain containing 78 171388 124093 0.48
ACOT13 Acyl-coenzyme A thioesterase 13 (THEM2) 137024 55856 0.46
C12orf43 Chromosome 12 open reading frame 43 230584 64897 0.46
DHX34 DEAH (Asp-Glu-Ala-His) box polypeptide 34 210135 9704 0.45
PRAC Prostate cancer susceptibility candidate (C17orf92) 177570 84366 20.64
HGS Hepatocyte growth factor-regulated tyrosine kinase substrate 118384 9146 20.62
USP5 Ubiquitin specific protease 5 (isopeptidase T) 195536 8078 20.60
PLA2G6 Phospholipase A2, group VI (cytosolic, calcium-independent) 149260 8398 20.55
MRPL55 Mitochondrial ribosomal protein L55 216047 128308 20.55
SCARF1 Scavenger receptor class F member 1 172281 8578 20.54
OSBP2 Oxysterol-binding protein 2 148957 23762 20.50
ASCC2 Activating signal cointegrator 1 complex subunit 2 (p100) 186213 84164 20.50
NELF Nasal embryonic luteinizing hormone-releasing hormone factor 159936 26012 20.47
ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1 210662 9619 20.47
aComplete lists of differentially expressed genes (p#0.01) are given in Supplemental Table S4.
Abbreviations: ABI: Applied Biosystems.
doi:10.1371/journal.pone.0067270.t006
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lower PTAFR expression levels in the lowest LA/ALA decile. The
Fc receptor fragments FCGRT and FCER1B (also known as
MS4A2), as well as GTF2I, which is necessary for Fc heavy chain
transcription, were up-regulated in the highest LA/ALA decile in
our study. These fragments are part of the receptors for IgG and
IgE, respectively, which are essential mediators of hypersensitive
reactions. Conversely, the lower expression levels in the group with
favorable LA/ALA ratios, may be viewed as an indication of lower
immunological activation associated with lower ratio. The higher
expression level of SRGN in the highest LA/ALA decile may also
be indicative of hypersensitivity, as this protein is secreted from
mast cell granules upon activation. Furthermore, the granzyme B
inhibitor SERPINB9 was more highly expressed in the lowest total
n-6/n-3 decile, fitting with a reduced immunological activity in the
lowest FA ratio deciles.
A common denominator for the processes described above is the
relation to hypersensitive reactions in people with conditions like
asthma and allergies. Allergen binding to IgE and interaction with
the Fc receptor ultimately leads to a release of eicosanoids, platelet
activating factor, and cytokines like IL1. Collectively these
mediators lead to activation and recruitment of inflammatory
cells, which may be related to the increased expression of the
chemotactic CCL7 (in the highest LA/ALA decile) and CCL24 (in
the highest AA/EPA decile), and the cell migration-related
PLAUR (in the highest LA/ALA decile). Several of the identified
pathway-level results support this hypothesis. In contrast, we found
that a subunit of the antigen presenting MHC II complex, HLA-
DQA1, was down-regulated in the highest AA/EPA decile. The
molecular mechanisms described here in relation to immunor-
egluation by FAs, may be a part of the etiology of chronic
inflammatory diseases, as suggested by others [35]. Recently,
attention has been drawn to asthma and other atopic conditions as
risk factors for chronic inflammatory diseases like diabetes and
coronary heart disease [36]. The mechanisms of this association
remain unclear, but immunological dysregulation is emerging as a
potential link between atopy and chronic diseases [37]. Diet is a
modifiable risk factor for several chronic diseases, and the gene
expression patterns described here may constitute part of the
complex and multifactorial links between diet, chronic inflamma-
tory diseases, and atopic conditions.
Contrary to our prior hypothesis, few genes related to
inflammatory signaling pathways were differentially expressed
according to AA/EPA ratio. AA and EPA are precursors of a
variety of inflammatory signaling molecules, and are fundamental
to the implication of dietary PUFAs in inflammation [1].
However, in line with our results on gene expression in circulating
blood cells, a recent review could make no firm conclusions about
marine n-3 PUFAs and circulating inflammatory markers in
healthy individuals, or in individuals with risk factors for
cardiovascular disease [38].
The PPARc Pathway may be Modulated by FA Ratios
Several genes related to lipid metabolism were differentially
expressed according to FA ratios, and this was reflected in the
pathway level analysis as well. Significant overlaps with reported
gene sets from MSigDB included phospholipid transporter activity
and Kegg ABC transporters (associated with the AA/EPA ratio),
as well as post Golgi vesicle mediated transport and intracellular
transport (associated with the total n-6/n-3 ratio). According to
LA/ALA ratio, no pathway level processes were significant, but
key FA metabolism regulators like RXRA, FABP4 (both binding
partners for PPARc), and ADIPOR1 were differentially expressed.
These key regulators have been implicated in the pathogenesis of
atherosclerosis, diabetes and metabolic diseases [39–41]. The
PPARc target ABCG1 was one of very few genes that were
significantly associated with more than one FA ratio: it was
expressed at lower levels in the highest AA/EPA and n-6/n-3
deciles. ABCG1 promotes cholesterol efflux from macrophages,
and reduced expression in diabetics was related to increased foam
cell formation [42]. The association of low ABCG1 levels with
higher FA ratios in our dataset may provide hints to important
Table 7. Significant overlaps between differentially expressed
genes and reported gene sets in MSigDBa.
FA ratio Gene Set Name K k k/K
LA/ALA
KRCTCNNNNMANAGC Unknown 60 6 10%
Immune response 232 11 5%
Reactome Packaging of telomere
ends
49 5 10%
Reactome Telomere maintenance 77 6 8%
Immune system process 326 12 4%
Kegg nitrogen emtabolism 23 3 13%
RYTAAWNNNTGAY Unknown 53 4 8%
Locomotory behavior 91 5 5%
Positive regulation of defence
response
10 2 20%
Response to external stimulus 306 10 3%
Reactome RNA Pol I promoter
opening
59 4 7%
Reactome DNA strand elongation 31 3 10%
Hydrolase activity acting on ester
bonds
264 9 3%
Reactome Unwinding of DNA 11 2 18%
Cofactor transport 11 2 18%
Reactome Signal attenuation 11 2 18%
AA/EPA
Phospholipid transporter activity 12 2 17%
Lipid transporter activity 27 2 7%
Nuclear body 33 2 6%
TCTAGAG, MIR-517 37 2 5%
Kegg ABC Transporters 44 2 5%
Total n-6/n-
3
Biocarta Mitochondria pathway 21 2 14%
Reactome Intrinsic pathway for
apoptosis
29 3 4%
Apoptotic program 60 2 10%
CCCAGAG,MIR-326 135 4 3%
SCGGAAGY_V$ELK1_02 822 6 2%
Post Golgi vesicle mediated
transport
14 2 7%
Intracellular transport 271 5 2%
aThe table is sorted by p-values with the lowest first, all p-values,0.01. Number
of genes submitted for comparison was 184 for LA/ALA, 36 for AA/EPA, and 65
for n-6/n-3. Gene sets significant at p,0.05 are provided in Supplemental
Tables S5–S7.
Abbreviations: AA: arachidonic acid, ALA: alpha-linolenic acid, EPA:
eicosapentaenoic acid, FA: fatty acid, K: number of genes in gene set, k: number
of genes in overlap, LA: linoleic acid.
doi:10.1371/journal.pone.0067270.t007
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atherogenic consequences of ratios dominated by n-6 FAs. Taken
together, one may speculate that the PPARc pathway is
modulated by differing FA ratios, and that possible health gains
may be achieved via this pathway, by lowering FA ratios that are
dominated by n-6 FAs.
FA Ratios may Influence Autophagy
Unexpectedly, several genes related to autophagy were expressed
at higher levels in the lowest deciles of all FA ratios. Key genes
included the positive regulator KIAA0831 (also known as Barkor/
Atg14, up-regulated in lowest LA/ALA) and OPTN (also known as
FIP2, up-regulated in the lowest LA/ALA and total n-6/n-3
deciles). Autophagy is emerging as a highly specific and diverse
mechanism for lysosomal degradation of intracellular material, with
numerous implications for cellular homeostasis, nutrient sensing,
insulin regulation, and cholesterol metabolism [43]. Data is
accumulating that demonstrates the close link between lipid
metabolism and autophagy: lipid droplets may be degraded by
autophagy, modulation of membrane lipids is essential for the
process, and lipid modifying proteins have important regulatory
roles [44]. Related processes include the inositol phosphate
signaling system, endoplasmic reticulum stress, and oxysterol
metabolism, all of which were reflected in our gene expression
data. In line with our findings related to lipid metabolism and
autophagy markers, a very recent cell line study showed induction of
autophagy after n-3 FA supplementation, via the PPARc pathway
[45]. The potential influence of FA ratios on autophagy, and the
impact of autophagy on health and disease, warrants further study.
miRNAs and unknown Transcription Factor Motifs
Differentially expressed genes derived from all FA ratios
significantly overlapped with one or more gene sets that included
targets of specific miRNAs. For example, miRNAs related to AA/
EPA ratio included MIR-103/2107 and MIR-7, both shown to
be involved in insulin and insulin-like growth factor signaling
[46,47]. Total n-6/n-3 ratio was associated with MIR-326, which
is involved in autoimmune diseases [48], and MIR-296, which is
involved in regulation of angiogenesis [49] and lipoapoptosis [50].
Transcriptional regulation by miRNAs may emerge as a
mechanism for fine-tuning cellular and physiological responses
to FAs. Furthermore, gene expression profiles according to LA/
ALA and total n-6/n-3 ratios overlapped with gene sets containing
common promoter motifs matching unknown transcription
factors. One could speculate that transcription factors as yet
unidentified may play a role in the complex transcriptional
regulation in response to dietary lipids.
Strengths and Limitations
Because the Norwegian population consumes comparably high
amounts of n-3 PUFAs, they constitute a ‘‘natural experiment’’ for
exploring the potential effects of FA ratios. However, several issues
arise in the interface between epidemiologic and molecular
research. First, as this is an explorative, cross-sectional study, no
conclusions can be made regarding causal mechanisms. Impor-
tantly, residual bias may be present in the data set, for example
related to age, ongoing infections, or the variation in time since
previous meal before blood sample collection.
There was a small, but statistically significant age difference
between women in the highest versus lowest AA/EPA and total n-
6/n-3 deciles. This was likely related to the finding that n-3
supplement users were slightly older than non-users in the study
population. Age is known to influence metabolism of n-3 PUFAs,
particularly during menopause. However, due to the use of
supplements, the small age differences (3 years for AA/EPA ratio,
and 4 years for total n-6/n-3 ratio), and our confirmed data on
menopausal status, we chose not to adjust for age. This may have
introduced bias in the data. Additional bias may have been
introduced by confounders on which we had either limited or no
information. For example, disease status could only be inferred
from self-reported medication use, and no data on the distribution
of blood cell subtypes were available. Because the PAXgene Blood
RNA kit preserves RNA from all circulating cells, fluctuating levels
of blood cell subtypes related to an infection may influence gene
expression profiles. The use of medication was not statistically
different between comparison groups, but sub-clinical infections
could still introduce differences in blood cell subtypes, and in turn,
in the gene expression profiles.
In our study design, study women were not asked to fast before
blood collection. Humans spend the majority of the day in a non-
fasted, postprandial state, with a continuous fluctuation in the
degree of lipemia [51]. Our biomarker of exposure, plasma total
FAs, includes both the highly variable triglycerides (varies within
hours and reflects FA content of the previous meal [52]), the
cholesterol esters and phospholipids (varies within days) and the
more stable non-esterified (free) FAs [53]. Thus, this biomarker
may be said to reflect both intake and metabolism, and has been
judged a valid biomarker, particularly for the exogenously derived
long-chain PUFAs [53]. However, this biomarker renders us
Table 8. Gene Set Enrichment Analysis.
FA ratioa
Gene
set Size Title NES NOM p FDR q
LA/ALA
BP00117 26 Jak-STAT cascade 1.79 0.01 0.23
GO_0006913 30 Nucleocytoplasmic transport 21.80 0.01 0.16
GO_0051169 30 Nuclear transport 21.80 0.01 0.16
GO_0051188 25 Cofactor biosynthetic process 21.61 0.03 0.22
GO_0051168 17 Nuclear export 21.61 0.03 0.24
AA/EPA
BP00101 19 Sulfur metabolism 22.07 ,0.01 ,0.01
aThere were no significantly enriched gene sets related to n-6/n-3.
Abbreviations: AA: arachidonic acid, ALA: alpha-linolenic acid, EPA: eicosapentaenoic acid, FA: fatty acid, FDR: false discovery rate, LA: linoleic acid, NES: normalized
enrichment score, NOM p: nominal p-value.
doi:10.1371/journal.pone.0067270.t008
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unable to differentiate between short- versus long-term exposure to
FAs. Studies have shown differing gene expression profiles after
short (postprandial) and long-term exposure to n-3 FAs.
Postprandially, genes involved in lipid metabolism were regulated
[19], and after long-term exposure inflammatory signaling was
regulated [5]. In line with the properties of plasma FA ratios as a
biomarker of exposure, we identified gene expression differences
related to both lipid metabolism and inflammation.
Regarding the data analysis, GSEA can only identify gene sets
that are being used as input, in this case pathways from KEGG,
GO, and Panther. Recently characterized pathways like autoph-
agy may be reported to involve somewhat non-overlapping sets of
genes according to different databases, which poses difficulties for
GSEA and overlap analysis. Lastly, we did not validate gene
expression levels using other methods like quantitative real-time
polymerase chain reaction or independent data sets, and our
results must be interpreted accordingly.
Conclusions
We conclude that the plasma ratios of LA/ALA, AA/EPA and
total n-6/n-3 may have differential impacts on blood gene
expression in this cross-section of Norwegian middle-aged women.
Genes and pathways associated with differing FA ratios may
provide links to potential health consequences related to the
balance of n-6 and n-3 PUFAs. Increased knowledge and
awareness of the metabolic actions of dietary PUFAs is warranted,
in order to form a sound basis on which to deliver evidence-based
nutritional advice to the public.
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